Evidence map›Paper›PMID 28453768›Full record

ArticleJournal of Crohn's & colitis2017

αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis.

Christopher A Lamb, John C Mansfield, Gaik W Tew, Deena Gibbons, Anna K Long, Peter Irving, Lauri Diehl, Jeff Eastham-Anderson, Maria B Price, Graeme O'Boyle and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Crohn's & colitis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Meta-analysis of etrolizumabTherapeutic advances in gastroenterology · 2024
    Article
  10. CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease.International journal of molecular sciences · 2023
    Review
  11. Targeting integrin pathways: mechanisms and advances in therapy.Signal transduction and targeted therapy · 2023
    Review
  12. CSK-mediated signalling by integrins in cancer.Frontiers in cell and developmental biology · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Targeting Leukocyte Trafficking in Inflammatory Bowel Disease.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Christopher A LambInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
John C MansfieldDepartment of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.
Gaik W TewResearch & Early Development, Genentech, South San Francisco, CA 94080, USA.
Deena GibbonsPeter Gorer Department of Immunobiology, King's College London, London SE1 9RT, UK.
Anna K LongDepartment of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.
Peter IrvingPeter Gorer Department of Immunobiology, King's College London, London SE1 9RT, UK.
Lauri DiehlResearch & Early Development, Genentech, South San Francisco, CA 94080, USA.
Jeff Eastham-AndersonResearch & Early Development, Genentech, South San Francisco, CA 94080, USA.
Maria B PriceDepartment of Gastroenterology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne NE1 4LP, UK.
Graeme O'BoyleInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
David E J JonesInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Sharon O'ByrneResearch & Early Development, Genentech, South San Francisco, CA 94080, USA.
Adrian HaydayPeter Gorer Department of Immunobiology, King's College London, London SE1 9RT, UK.
Mary E KeirResearch & Early Development, Genentech, South San Francisco, CA 94080, USA.
Jackson G EgenResearch & Early Development, Genentech, South San Francisco, CA 94080, USA.
John A KirbyInstitute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Genesys (United States) · USNewcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GBKing's College London · GBCancer Research UK · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

BACKGROUND AND

aimsThe αEβ7 integrin is crucial for retention of T lymphocytes at mucosal surfaces through its interaction with E-cadherin. Pathogenic or protective functions of these cells during human intestinal inflammation, such as ulcerative colitis [UC], have not previously been defined, with understanding largely derived from animal model data. Defining this phenotype in human samples is important for understanding UC pathogenesis and is of translational importance for therapeutic targeting of αEβ7-E-cadherin interactions.

methodsαEβ7+ and αEβ7- colonic T cell localization, inflammatory cytokine production and expression of regulatory T cell-associated markers were evaluated in cohorts of control subjects and patients with active UC by immunohistochemistry, flow cytometry and real-time PCR of FACS-purified cell populations.

resultsCD4+αEβ7+ T lymphocytes from both healthy controls and UC patients had lower expression of regulatory T cell-associated genes, including FOXP3, IL-10, CTLA-4 and ICOS in comparison with CD4+αEβ7- T lymphocytes. In UC, CD4+αEβ7+ lymphocytes expressed higher levels of IFNγ and TNFα in comparison with CD4+αEβ7- lymphocytes. Additionally the CD4+αEβ7+ subset was enriched for Th17 cells and the recently described Th17/Th1 subset co-expressing both IL-17A and IFNγ, both of which were found at higher frequencies in UC compared to control.

conclusionαEβ7 integrin expression on human colonic CD4+ T cells was associated with increased production of pro-inflammatory Th1, Th17 and Th17/Th1 cytokines, with reduced expression of regulatory T cell-associated markers. These data suggest colonic CD4+αEβ7+ T cells are pro-inflammatory and may play a role in UC pathobiology.

Indexed as

AdultAgedCase-Control StudiesCD4-Positive T-LymphocytesColitis, UlcerativeColonCytokinesFemaleFlow CytometryHumansIntegrinsMaleMiddle AgedReal-Time Polymerase Chain ReactionYoung AdultCytokinesintegrin alphaEbeta7IntegrinsCD103CD4+ T cellcytokineeffector T celletrolizumabhelper T cellinflammatory bowel diseaseintraepithelial lymphocytesmucosal immunologyregulatory T cellTh1Th17Th17/1Tregulcerative colitisαEβ7 integrin

Identifiers

PMID28453768
PMCPMC5815571
OpenAlexW2532628390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.